Why cannabis company MGC Pharmaceuticals rocketed 38% higher today

The MGC Pharmaceuticals Ltd (ASX:MXC) share price rocketed 38% higher on Wednesday. Here's why this cannabis company smoked the market…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the best performers on the Australian share market on Wednesday has been the MGC Pharmaceuticals Ltd (ASX: MXC) share price.

At one stage today the cannabis company's shares were up as much as 38% to 5.8 cents.

They have since given back some of these gains, but are still a sizeable 21% higher at 5.1 cents in afternoon trade.

Why is the MGC Pharmaceuticals share price rocketing higher?

This morning MGC Pharmaceuticals announced that it has signed a marketing, sales, and distribution agreement to provide its cannabidiol (CBD) and hemp-enhanced Nutraceutical product line into the Chinese health products market through a tailored campaign designed with Chinese specialist e-commerce retailer YuShop Global.

These products include CBD Hemp protein powder, BCAA CBD capsules, CBD Water Soluble Solution and CBD herbal V-Pen.

The release explains that this is a Business to Customer (B2C) services agreement, with YuShop responsible for collecting and transferring sales proceeds to MGC Pharma immediately post completion of transactions.

There are no specified minimum contract amounts or volumes under this agreement.

What is YuShop?

YuShop is a specialist in the import and commercialisation of innovative health and wellness consumables. It provides its merchant partners a turn-key solution for marketing, importing, and selling their products directly to the middle-class and affluent Chinese consumer through their cross-border digital commerce platform.

It provides MGC Pharmaceuticals access to over 1,500 retail channel partner outlets as well as online, app-based, storefronts that will make the Nutraceutical product line available to the market of over 350 million middle-class Chinese vitamin and supplements consumers.

According to management, the Chinese consumer market is forecast to purchase over US$20 billion of vitamins and supplements in 2020, with foreign products being in high demand because of the perceived superior quality and reduced counterfeit products often associated with domestic brands.

Should you invest?

Whilst I think this is a promising development for the company, only time will tell whether it is the next Blackmores Limited (ASX: BKL).

I would suggest investors sit this one out for a couple of quarters and see how sales of its products grow. In the meantime, I would focus on other China-focused exporters such as A2 Milk Company Ltd (ASX: A2M) or Bellamy's Australia Ltd (ASX: BAL).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »